Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-015745
Filing Date
2015-08-13
Accepted
2015-08-13 16:17:47
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20150630_10q.htm 10-Q 931982
2 EXHIBIT 4.7 ex4-7.htm EX-4.7 117258
3 EXHIBIT 4.9 ex4-9.htm EX-4.9 162374
4 EXHIBIT 10.1 ex10-1.htm EX-10.1 233516
5 EXHIBIT 10.2 ex10-2.htm EX-10.2 73531
6 EXHIBIT 31.1 ex31-1.htm EX-31.1 10809
7 EXHIBIT 31.2 ex31-2.htm EX-31.2 10644
8 EXHIBIT 32.1 ex32-1.htm EX-32.1 4966
9 EXHIBIT 32.2 ex32-2.htm EX-32.2 4874
  Complete submission text file 0001437749-15-015745.txt   5125007

Data Files

Seq Description Document Type Size
10 EXHIBIT 101.INS nby-20150630.xml EX-101.INS 949963
11 EXHIBIT 101.SCH nby-20150630.xsd EX-101.SCH 46642
12 EXHIBIT 101.CAL nby-20150630_cal.xml EX-101.CAL 32038
13 EXHIBIT 101.DEF nby-20150630_def.xml EX-101.DEF 209583
14 EXHIBIT 101.LAB nby-20150630_lab.xml EX-101.LAB 317772
15 EXHIBIT 101.PRE nby-20150630_pre.xml EX-101.PRE 215076
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 151050919
SIC: 2834 Pharmaceutical Preparations